Air-in-Line Alarms: Decreasing Alarms Through Antisiphon Valve Implementation.

Area of Science:

• Oncology
• Pharmacology
• Medical Devices

Background:

• Continuous chemotherapy infusions, like EPOCH, are standard treatments.
• These infusions frequently generate clinically insignificant air-in-line (AIL) alarms due to drug composition.
• Frequent AIL alarms can disrupt treatment and workflow.

Purpose of the Study:

• To evaluate the efficacy of an antisiphon valve in reducing AIL alarms.
• To assess the impact of antisiphon valves on chemotherapy infusion management.
• To determine if this intervention can be applied to other problematic infusions.

Main Methods:

• An antisiphon valve was incorporated into the IV tubing setup.
• The valve was positioned at the distal end of the infusion line.
• Continuous chemotherapy infusions, specifically EPOCH regimens, were monitored for AIL alarms before and after valve implementation.

Main Results:

• The antisiphon valve significantly decreased the frequency of clinically insignificant AIL alarms.
• The valve functions by pressurizing the infusion and minimizing air bubble formation.
• This intervention offers a practical solution for managing frequent AIL alarms.

Conclusions:

• Antisiphon valves are effective in reducing false AIL alarms during continuous chemotherapy.
• This technology can improve the efficiency and reliability of chemotherapy administration.
• The findings suggest broader applicability to other infusions prone to AIL alarms.